Lin Xiao | Cellular Neuroscience | Best Researcher Award

Dr. Lin Xiao | Cellular Neuroscience | Best Researcher Award

Dr. Lin Xiao | Institute for Brain Research and Rehabilitation | China

Dr. Lin Xiao is a distinguished Professor of Neuroscience at the Institute for Brain Research and Rehabilitation, South China Normal University, whose pioneering research has significantly advanced understanding of oligodendrocyte biology and myelin plasticity. His work elucidates the mechanisms by which adaptive myelination contributes to motor learning and memory, proposing a novel “biphasic plasticity model” that distinguishes distinct phases of learning and consolidation. Dr. Xiao’s research has been published in leading journals including Nature Neuroscience, Science, Nature Communications, and Advanced Science, collectively garnering over 2,800 citations and an h-index of 28, with approximately 20 peer-reviewed articles. His landmark paper in Nature Neuroscience has become a classic reference with over 500 citations, demonstrating substantial influence in the field. He has led multiple projects funded by the National Natural Science Foundation of China, including completed and ongoing studies, and established major collaborations with institutions such as University College London. His research areas include glial–neuron interactions, mechanisms of remyelination, neurodevelopmental disorders such as autism, and psychiatric disorders including depression. These contributions have been recognized with national awards and have opened promising avenues for therapeutic strategies in demyelinating and cognitive disorders.

Profiles: Google Scholar | Orcid | Research Gate  

Featured Publications

Marques, S., Zeisel, A., Codeluppi, S., Van Bruggen, D., Mendanha Falcão, A., et al. (2016). Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science, 352(6291), 1326–1329.

Xiao, L., Ohayon, D., McKenzie, I. A., Sinclair-Wilson, A., Wright, J. L., Fudge, A. D., et al. (2016). Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning. Nature Neuroscience, 19(9), 1210–1217.

Liu, S., Yu, M., He, Y., Xiao, L., Wang, F., Song, C., Sun, S., Ling, C., & Xu, Z. (2008). Melittin prevents liver cancer cell metastasis through inhibition of the Rac1‐dependent pathway. Hepatology, 47(6), 1964–1973.

Li, C., Xiao, L., Liu, X., Yang, W., Shen, W., Hu, C., Yang, G., & He, C. (2013). A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination. Glia, 61(5), 732–749.

Feng, P. A. N. (2003). Fast mode decision for intra prediction. JVT-G013, March 2003.

Li, Y. X., Ding, S. J., Xiao, L., Guo, W., & Zhan, Q. (2008). Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1α and erythropoietin. Neuroscience Bulletin, 24(2), 89–95.

Kumud Bala | Molecular and Cellular Neuroscience | Excellence in Research Award

Prof. Kumud Bala | Molecular and Cellular Neuroscience | Excellence in Research Award

Prof. Kumud Bala, Amity University, India.

Prof. Kumud Bala is a seasoned academic and researcher in the fields of biotechnology and immunology, with a rich educational background that includes a Ph.D. from Patna University in collaboration with AIIMS. She has over 25 years of teaching and research experience, primarily at Amity University, Noida, where she currently holds the position of Professor at the Amity Institute of Biotechnology. Her professional journey has been marked by consistent progression, interdisciplinary teaching, and impactful research. She has contributed significantly to biotechnology education through curriculum development, student mentorship, and translational research projects that align closely with real-world biomedical challenges.

Profile

Google Scholar
Orcid
Scopus

Early Academic Pursuits

Prof. Kumud Bala’s academic journey began with a strong foundation in the life sciences at Patna University, where she earned her B.Sc. in Zoology in 1992, followed by an M.Sc. in Immunology in 1995. Her passion for understanding the intricate mechanisms of biological systems led her to pursue a Ph.D. in Biotechnology, a collaborative program between Patna University and AIIMS, which she successfully completed in 2003. This solid educational background laid the groundwork for her long-standing academic and research career in the field of biotechnology and immunology.

Professional Endeavors in Higher Education

Prof. Bala has cultivated a distinguished teaching and research career over nearly three decades, beginning in 1996 as a Lecturer at St. Columba’s College, Hazaribag, where she contributed for over a decade. She later joined Amity University, Noida, where she steadily rose through the academic ranks—from Senior Lecturer at the Amity Institute of Advanced Training and Research to Expert Faculty at the Amity Institute of Pharmacy, and eventually to Assistant Professor III in 2009. Her dedication and academic excellence led to her promotion as Associate Professor in 2013, and she currently serves as a Professor at the Amity Institute of Biotechnology since 2019. Her professional journey is a testament to her unwavering commitment to knowledge dissemination and academic leadership.

Contributions and Research Focus

Prof. Bala’s research primarily revolves around biotechnology and immunology, with deep insights into molecular mechanisms of disease, therapeutic interventions, and diagnostic innovations. Her work often bridges interdisciplinary domains, particularly in translational research aimed at addressing immunological disorders and enhancing biotechnological applications in healthcare. Through her roles in academia, she has significantly contributed to shaping curricula, mentoring research scholars, and advancing scientific inquiry in life sciences. Her scholarly output reflects a commitment to both foundational and applied research in biomedical biotechnology.

Accolades and Recognition

While explicit accolades are not detailed in the record, Prof. Bala’s rise through academic ranks and continued tenure at a leading private university in India—Amity University—indicates a high level of institutional recognition. Her roles have involved strategic responsibilities in curriculum development, research coordination, and interdisciplinary teaching, underscoring her reputation as a trusted educator and researcher. The trust placed in her for long-term roles across diverse faculties also reflects professional respect and recognition among peers.

Impact and Influence on Biotechnology Education

Prof. Bala has profoundly influenced biotechnology education in India through her dynamic teaching methodologies and innovative research projects. Her involvement in training students from pharmacy, advanced research, and biotechnology backgrounds positions her at the center of a multidisciplinary educational landscape. Her ability to integrate academic theory with practical applications has shaped the perspectives of numerous undergraduates, postgraduates, and research aspirants, many of whom have pursued impactful careers in biomedical sciences and allied fields.

Legacy in Research and Mentorship

A hallmark of Prof. Bala’s career is her enduring legacy as a mentor and scientific guide. Her role in mentoring early-career scientists and guiding them through complex research problems stands as one of her most valuable contributions to academia. Her collaborative ethos, combined with her scientific rigor, has fostered a culture of excellence and innovation. Her efforts have ensured that research in biotechnology not only thrives in academic settings but also responds to real-world health challenges.

Future Vision and Continuing Contributions

Looking ahead, Prof. Kumud Bala continues to be an influential voice in biotechnology and immunology, actively participating in the academic and scientific community at Amity University and beyond. With the growing importance of biotechnology in global healthcare, she is uniquely positioned to lead future projects focused on interdisciplinary research, biomedical innovation, and policy-oriented science education. Her unwavering commitment to scientific growth and mentorship guarantees that her impact will be felt for generations to come.

Publication

1. Morphological examination of ear: a study of an Indian population – PK Chattopadhyay, S Bhatia – 2009


2. Herbal contraceptive: an overview – K Bala, M Arya, DP Katare – 2014


3. Adverse effect of combined oral contraceptive pills – A Shukla, R Jamwal, K Bala – 2017


4. Dealing Wildlife Offences in India: Role of the Hair as Physical Evidence – VT V Sahajpal, SP Goyal, Kumudbala Singh – 2009


5. In vitro antioxidant activity of defatted seed extracts of Ocimum sanctum on rat PC-12 cells and its inhibitory efficacy with receptors of oral squamous cell carcinoma – Y Sharma, M Bharadwaj, N Srivastava, A Kaur, M Kumar, M Agarwal, … – 2020


6. In-vitro antiproliferative efficacy of Abrus precatorius seed extracts on cervical carcinoma – A Kaur, Y Sharma, A Kumar, MP Ghosh, K Bala – 2022


7. Antioxidant activity of polyphenolic flavonoid of stem of Nicotiana tabacum – Y Sharma, A Nagar, NS Srivastava, K Bala – 2017


8. Comparative study of different parts of fruits of Musa Sp. on the basis of their antioxidant activity – Y Sharma, A Chauhan, K Bala, A Nagar – 2016


9. Preclinical assessment of stem of Nicotiana tabacum on excision wound model – Y Sharma, A Kaur, R Bhardwaj, N Srivastava, M Lal, S Madan, K Bala – 2021


10. Nosocomial infection by non-fermenting gram negative bacilli in tertiary care hospital: Screening and cure – R Wadhwa, Y Sharma, RP Upadhyay, K Bala – 2016

 

Conclusion

Prof. Kumud Bala’s career reflects a strong blend of academic rigor, research excellence, and educational leadership. Through her deep involvement in immunology and biotechnology, she has shaped the academic paths of numerous students and contributed to advancing science education in India. Her enduring commitment to scientific inquiry, mentorship, and innovation positions her as a respected figure in her field. Moving forward, her work promises to continue influencing both academic advancement and practical healthcare solutions, reinforcing her role as a pivotal contributor to the growth of life sciences in higher education.

 

Peng Jun | Cellular Neuroscience | Best Researcher Award

Prof. Peng Jun | Cellular Neuroscience | Best Researcher Award

Prof. Peng Jun, Qilu hospital of Shandong University, China.

Professor Jun Peng is a distinguished leader in hematology, currently serving as Vice President of Qilu Hospital of Shandong University and Director of the Department of Hematology. His research is deeply rooted in the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP), where he has made significant breakthroughs, including the publication of 14 papers in Blood. With a career supported by prestigious national awards, and leadership in 15 high-level research projects, Professor Peng is also a vital figure in Chinese hematology societies and editorial boards of leading journals. His academic rigor, clinical insight, and mentorship continue to shape the future of hematological science in China and beyond.

Profile

Scopus

🎓 Early Academic Pursuits

Professor Jun Peng embarked on his academic journey with a strong commitment to medicine and hematological sciences. From the outset, he exhibited exceptional academic talent and dedication, leading him to pursue both an M.D. and Ph.D. His early education laid a robust foundation for his future specialization in hematology, particularly in the complex field of immunological disorders. His doctoral work, recognized nationally, foreshadowed the groundbreaking contributions he would later make in immune thrombocytopenia research.

🩺 Professional Endeavors

Currently serving as the Vice President of Qilu Hospital of Shandong University, Professor Peng also holds the roles of Chief Physician, Professor, and Ph.D./M.D. Advisor, in addition to being the Director of the Department of Hematology. His clinical and academic responsibilities are carried out with unwavering diligence, mentoring future medical experts while overseeing high-level clinical operations. As a Distinguished Professor of Shandong University, he is actively engaged in shaping the university’s medical excellence on both national and global stages.

🔬 Contributions and Research Focus

At the heart of Professor Peng’s career is his pioneering work on the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP). He has made substantial contributions to understanding the autoimmune mechanisms that underlie ITP, one of the most challenging hematologic disorders. His scholarly dedication is evidenced by the publication of 14 papers in Blood, a leading journal in hematology, where he served as corresponding or co-corresponding author. His research, grounded in clinical insight and scientific precision, has contributed new perspectives on immune regulation in hematologic diseases.

🏆 Accolades and Recognition

Professor Peng’s excellence has been recognized with numerous prestigious awards. These include the National Science Fund for Distinguished Young Scholars, which highlights his scientific creativity and impact at a young age. He is also a recipient of the One-Hundred National Outstanding Doctoral Dissertation Award, a testament to the academic rigor of his early research. Additionally, he earned the First Prize of the Natural Science Award for Outstanding Achievements in Scientific Research from the Ministry of Education and the Science and Technology Progress Award, reflecting both his academic brilliance and practical impact in the medical field.

🧪 Impact and Influence

Beyond research publications, Professor Peng has significantly influenced the broader scientific and medical communities. As a principal investigator, he has led fifteen national and ministerial-level research projects, including those funded by the National Natural Science Foundation of China and the 973 Program under the Ministry of Science and Technology. His leadership extends to active roles in national academic societies, including the Thrombosis and Hemostasis Group of the Chinese Society of Hematology and the Professional Committee of Experimental Hematology of the Chinese Society of Pathophysiology. These positions allow him to shape the direction of hematological research and clinical guidelines in China.

📚 Academic Leadership and Editorial Roles

A passionate advocate for knowledge dissemination, Professor Peng is a key editorial board member for several respected journals such as Thrombosis Journal, Thrombosis Research, Journal of Clinical Hematology, and the Chinese Journal of Hematology. Through these roles, he ensures that cutting-edge research in hematology is critically evaluated and shared widely, fostering a culture of scientific excellence and collaboration across the globe.

🌟 Legacy and Future Contributions

Professor Jun Peng’s legacy is being forged not only through his past achievements but also through his continued commitment to the advancement of hematological science. His influence spans clinical innovation, academic mentorship, and scientific discovery. As he continues to push the boundaries of understanding in ITP and immune tolerance, he inspires a new generation of physician-scientists. The impact of his work promises to resonate for years to come, offering hope and healing for patients and propelling China’s medical research onto the world stage.

Publication

  • Title: Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
    Authors: Qizhao Li, Geneviève Marcoux, Yuefen Hu, Jung Peng, John W. Semple
    Year: 2024

 

  • Title: Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases
    Authors: Tianzi Jian, Fabao Xu, Guihua Li, Li Zhang, Jung Peng
    Year: 2024

 

  • Title: Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
    Authors: Ju Li, Cheng Zhang, Yuefen Hu, Qi Feng, Xiang Hu
    Year: 2024

 

  • Title: The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)
    Authors: Lin Sun, Yichen Zhang, Ping Chen, Jung Peng, Zi Sheng
    Year: 2024

 

  • Title: Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review
    Authors: You Yuan Su, Yafei Yu, Zhenyu Yan, Jung Peng, Xinguang Liu
    Year: 2024

 

  • Title: Ion channel Piezo1 activation aggravates the endothelial dysfunction under a high glucose environment
    Authors: Xiaoyu Zhang, Shaoqiu Leng, Xinyue Liu, Shuwen Wang, Jung Peng
    Year: 2024

 

  • Title: Intelligent dual-modality label-free cell classification with light scattering imaging and Raman spectra measurements
    Authors: Faihaa Mohammed Eltigani, Xiaoyu Zhang, Min Liu, Jung Peng, Xuantao Su
    Year: 2024

 

  • Title: Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial
    Authors: Lu Sun, Xiaoyang Huang, Juan Wang, Ming Hou, Yu Hou
    Year: 2024

 

  • Title: Risk Factors for Mortality in Critically Ill Patients with Coagulation Abnormalities: A Retrospective Cohort Study
    Authors: Qiuyu Guo, Jung Peng, Tichao Shan, Miao Xu
    Year: 2024

 

  • Title: Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
    Authors: Lingjun Wang, Haoyi Wang, Mingfang Zhu, Ming Hou, Yu Hou
    Year: 2024

 

✅ Conclusion

Through his pioneering research, unwavering clinical dedication, and impactful academic leadership, Professor Jun Peng stands at the forefront of immuno-hematology. His work not only deepens scientific understanding of ITP but also contributes directly to improved patient outcomes. As he continues to inspire through teaching, research, and innovation, Professor Peng’s legacy is one of excellence, influence, and ongoing transformation in the global hematology community.